Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Journal of Clinical Medicine|September 29, 2020
Ganglionated Plexi Ablation for the Treatment of Atrial FibrillationSahar Avazzadeh, Shauna McBride, Barry O'Brien, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 7, 2009
A review of the lung transplantation programme in Ireland 2005-2007Waldemar Bartosik, Jim J Egan, Alan Soo, et al.
Oncology Letters|May 14, 2021
Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factorsReagan Entigu Linton, Maelinda Daker, Alan Soo-Beng Khoo, et al.
Nutrition and Cancer|April 10, 2020
Cytotoxic Activity of Boesenbergia rotunda Extracts against Nasopharyngeal Carcinoma Cells (HK1). Cardamonin, a Boesenbergia rotunda Constituent, Inhibits Growth and Migration of HK1 Cells by Inducing Caspase-Dependent Apoptosis and G2/M-Phase ArrestMohammed Khaled Bin Break, Michelle Chiang, Christophe Wiart, et al.
Plos One|January 8, 2016
A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept StudySyed A Ali, Sin-Yeang Teow, Tasyriq Che Omar, et al.
Cancer Letters|October 29, 2011
Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cellsSoon Yang Low, Boon Shing Tan, Heng Lungh Choo, et al.
The Malaysian Journal of Medical Sciences : MJMS|April 25, 2013
Expression trend of selected ribosomal protein genes in nasopharyngeal carcinomaXiang-Ru Ma, Edmund Ui-Hang Sim, Teck-Yee Ling, et al.
Metallomics : Integrated Biometal Science|February 20, 2014
Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomesChew Hee Ng, Siew Ming Kong, Yee Lian Tiong, et al.
Molecular Medicine Reports|July 8, 2015
Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cellsLoong Hung Teng, Munirah Ahmad, Wayne Tiong Weng Ng, et al.
Molecular and Clinical Oncology|September 3, 2025
Silvestrol inhibits nasopharyngeal carcinoma cells and synergizes with CX-5461: Insights from a proteomics studyMaelinda Daker, Munirah Ahmad, Alan Soo-Beng Khoo, et al.
Pageof 13